Evidence Gaps

Anti‐TNF discontinuation vs anti‐TNF continuation

Down‐titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in… 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 733 participants
Moderate

Anti‐TNF dose reduction vs anti‐TNF continuation

Down‐titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in… 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 501 participants
High

Anti‐TNF disease activity–guided dose tapering vs anti‐TNF continuation

Down‐titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in… 2019 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 357 participants
Low